NM_004085.4:c.132+158A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004085.4(TIMM8A):​c.132+158A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.017 in 1,172,658 control chromosomes in the GnomAD database, including 160 homozygotes. There are 6,494 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 11 hom., 401 hem., cov: 21)
Exomes 𝑓: 0.018 ( 149 hom. 6093 hem. )

Consequence

TIMM8A
NM_004085.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.327

Publications

2 publications found
Variant links:
Genes affected
TIMM8A (HGNC:11817): (translocase of inner mitochondrial membrane 8A) This translocase is involved in the import and insertion of hydrophobic membrane proteins from the cytoplasm into the mitochondrial inner membrane. The gene is mutated in Mohr-Tranebjaerg syndrome/Deafness Dystonia Syndrome (MTS/DDS) and it is postulated that MTS/DDS is a mitochondrial disease caused by a defective mitochondrial protein import system. Defects in this gene also cause Jensen syndrome; an X-linked disease with opticoacoustic nerve atrophy and muscle weakness. This protein, along with TIMM13, forms a 70 kDa heterohexamer. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Mar 2009]
TIMM8A Gene-Disease associations (from GenCC):
  • deafness dystonia syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant X-101348375-T-C is Benign according to our data. Variant chrX-101348375-T-C is described in ClinVar as Benign. ClinVar VariationId is 44082.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0123 (1348/110006) while in subpopulation NFE AF = 0.0177 (929/52607). AF 95% confidence interval is 0.0167. There are 11 homozygotes in GnomAd4. There are 401 alleles in the male GnomAd4 subpopulation. Median coverage is 21. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TIMM8ANM_004085.4 linkc.132+158A>G intron_variant Intron 1 of 1 ENST00000372902.4 NP_004076.1
TIMM8ANM_001145951.2 linkc.*12A>G 3_prime_UTR_variant Exon 2 of 2 NP_001139423.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TIMM8AENST00000372902.4 linkc.132+158A>G intron_variant Intron 1 of 1 1 NM_004085.4 ENSP00000361993.3 O60220

Frequencies

GnomAD3 genomes
AF:
0.0123
AC:
1348
AN:
109950
Hom.:
11
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00206
Gnomad AMI
AF:
0.0613
Gnomad AMR
AF:
0.00938
Gnomad ASJ
AF:
0.0141
Gnomad EAS
AF:
0.000576
Gnomad SAS
AF:
0.0102
Gnomad FIN
AF:
0.0248
Gnomad MID
AF:
0.00424
Gnomad NFE
AF:
0.0177
Gnomad OTH
AF:
0.00605
GnomAD2 exomes
AF:
0.0136
AC:
1669
AN:
122550
AF XY:
0.0134
show subpopulations
Gnomad AFR exome
AF:
0.00120
Gnomad AMR exome
AF:
0.00662
Gnomad ASJ exome
AF:
0.0128
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0229
Gnomad NFE exome
AF:
0.0193
Gnomad OTH exome
AF:
0.0159
GnomAD4 exome
AF:
0.0175
AC:
18633
AN:
1062652
Hom.:
149
Cov.:
31
AF XY:
0.0176
AC XY:
6093
AN XY:
347068
show subpopulations
African (AFR)
AF:
0.00153
AC:
39
AN:
25414
American (AMR)
AF:
0.00619
AC:
176
AN:
28455
Ashkenazi Jewish (ASJ)
AF:
0.0131
AC:
245
AN:
18747
East Asian (EAS)
AF:
0.0000717
AC:
2
AN:
27906
South Asian (SAS)
AF:
0.0131
AC:
662
AN:
50699
European-Finnish (FIN)
AF:
0.0249
AC:
954
AN:
38285
Middle Eastern (MID)
AF:
0.00878
AC:
36
AN:
4098
European-Non Finnish (NFE)
AF:
0.0192
AC:
15811
AN:
824219
Other (OTH)
AF:
0.0158
AC:
708
AN:
44829
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
678
1356
2033
2711
3389
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
596
1192
1788
2384
2980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0123
AC:
1348
AN:
110006
Hom.:
11
Cov.:
21
AF XY:
0.0124
AC XY:
401
AN XY:
32342
show subpopulations
African (AFR)
AF:
0.00205
AC:
62
AN:
30201
American (AMR)
AF:
0.00936
AC:
97
AN:
10359
Ashkenazi Jewish (ASJ)
AF:
0.0141
AC:
37
AN:
2631
East Asian (EAS)
AF:
0.000577
AC:
2
AN:
3464
South Asian (SAS)
AF:
0.0103
AC:
26
AN:
2535
European-Finnish (FIN)
AF:
0.0248
AC:
144
AN:
5817
Middle Eastern (MID)
AF:
0.00463
AC:
1
AN:
216
European-Non Finnish (NFE)
AF:
0.0177
AC:
929
AN:
52607
Other (OTH)
AF:
0.00597
AC:
9
AN:
1507
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
50
99
149
198
248
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0145
Hom.:
115
Bravo
AF:
0.0107

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 03, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

*12A>G in Exon 02 of TIMM8A: This variant is not expected to have clinical signi ficance because it has been identified in 1.6% (30/1899) of European American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs41309506). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
11
DANN
Benign
0.78
PhyloP100
0.33
PromoterAI
0.054
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41309506; hg19: chrX-100603363; API